Benlysta

• Brands Benlysta
• Product Code: Benlysta

• Benlysta (belimumab) is a monoclonal antibody used to treat certain forms of lupus, including:

  • Systemic lupus erythematosus (SLE)

  • Lupus nephritis (a serious kidney complication of lupus)

  Benlysta works by targeting and inhibiting BLyS (B-lymphocyte stimulator), a protein that promotes the survival of B cells. Overactive B cells play a major role in lupus by attacking the body’s own tissues. By reducing the number of abnormal B cells, Benlysta helps control lupus flares and organ damage.

  Administration:

  • Given either as an intravenous (IV) infusion or a subcutaneous injection (auto-injector or prefilled syringe)

  • Dosing is typically weekly (injections) or monthly (infusions) after initial loading doses

  Common side effects:

  • Nausea

  • Diarrhea

  • Fever

  • Depression

  • Infusion reactions

  Serious risks:

  • Increased risk of infection

  • Allergic reactions

  • Mental health side effects, including suicidal thoughts in rare cases

  Benlysta is often used alongside other lupus medications like corticosteroids, antimalarials, or immunosuppressants.

• Availability: In Stock

• American Diabetes Association

• Diabetes Disaster_Response Coalition storing insulin

• FDA Approved Prescription